Indications |
Oral Allergic conditions Adult: 1 mg bid up to 2 mg bid, as needed. Alternatively, 0.5-1 mg at night for the 1st few days of treatment to minimise drowsiness. Child: 6 mth to 3 yr: 0.5 mg bid; >3 yr: 1 mg bid. Oral Asthma prophylaxis Adult: 1 mg bid up to 2 mg bid, as needed. Alternatively, 0.5-1 mg at night for the 1st few days of treatment to minimise drowsiness. Child: 6 mth to 3 yr: 0.5 mg bid; >3 yr: 1 mg bid. Ophthalmic Allergic conjunctivitis Adult: As 0.025% solution: Instill 1 drop into the affected eye(s) bid. Child: ≥3 yr: As 0.025% solution: Instill 1 drop into the affected eye(s) bid. |
Contraindications |
Acute asthma attack. |
Warnings / Precautions |
May impair tasks requring mental alertness e.g. driving or operating machinery. History of epilepsy. Pregnancy and lactation. Children <3 yr. |
Adverse Reactions |
Sedation, drowsiness, dizziness, dry mouth, weight gain, increased appetite, CNS stimulation. Rarely, cystitis. Conjunctival injection, headaches and rhinitis (ophthalmic). |
Overdose Reactions |
Symptoms: Drowsiness, confusion, dyspnoea, bradycardia or tachycardia, disorientation, convulsions, severe hypotension, reversible coma. Management: Supportive and symptomatic. |
Drug Interactions |
Reduced platelet count with oral antidiabetics. Potentially Fatal: May potentiate CNS effects of sedatives, hypnotics, antihistamines and alcohol. See Below for More ketotifen Drug Interactions |
Mechanism of Actions |
Ketotifen selectively and noncompetitively inhibits the release of mediators from cells involved in hypersensitivity reactions. It is also a mast cell stabiliser. Onset: Within min (ophthalmic). Absorption: Absorbed completely for the GIT (oral); bioavailability: 50%; peak plasma concentrations after 2-4 hr. Distribution: Protein-binding: 75%. Metabolism: Hepatic first-pass metabolism. Excretion: Via urine (as inactive metabolites and traces of unchanged drug); 21 hr (elimination half-life). |
Administration |
Should be taken with food. |
Storage Conditions |
Ophthalmic: Store at 25°C. Oral: Store below 25°C (77°F). |
ATC Classification |
R06AX17 - ketotifen ; Belongs to the class of other antihistamines for systemic use. S01GX08 - ketotifen ; Belongs to the class of other ophthalmologic antiallergics. |
Storage |
Ophthalmic: Store at 25°C. Oral: Store below 25°C (77°F). |
Available As |
|
Ketotifen
Post Review about Ketotifen Click here to cancel reply.
Ketotifen Containing Brands
Ketotifen is used in following diseases
Drug - Drug Interactions of Ketotifen
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.